Frédéric Vely

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Benjamin Besse, Mélinda Charrier, Valérie Lapierre et al. · OncoImmunology · 2015 · 754 citations · Full text

Immunology, Immunotherapeutics, Immunotherapy +20

Natural Killer Cell Signaling Pathways

Éric Vivier, Jacques A. Nunès, Frédéric Vely · Science · 2004 · 726 citations

Apoptosis, Immunology, Innate Immune System +16

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

Julien Carvelli, Olivier Demaria, Frédéric Vely et al. · Nature · 2020 · 528 citations · Full text

Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors

Charles A. Stewart, Fanny Laugier‐Anfossi, Frédéric Vely et al. · Proceedings of the National Academy of Sciences · 2005 · 391 citations · Full text

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases

Lucia Olcese, Philippe Lang, Frédéric Vely et al. · The Journal of Immunology · 1996 · 353 citations · Full text